Table 1.
Dose of TAC used by different authors when using TAC in monotherapy and in combination therapy
| Study | TAC dose and/or concentration | Associated treatment | Number of injections | Interval between sessions (weeks) |
|---|---|---|---|---|
| Rahban and Garner26 | 10 mg/mL | – | 2–3 | 4–8 |
| Darzi et al27 | 10–20 mg/cm2 | – | 4 | – |
| Robles et al9 | 10–40 mg/mL | – | Multiple | 4 |
| Acosta et al28 | 4–40 mg/mL | – | 1–5 | 4 |
| Ahuja and Chatterjee37 | 40 mg/mL | – | Maximum 8 | 3 |
| Danielsen et al38 | 1 mg/cm (maximum 5 mg) | Surgical excision (before TAC injection) | 4 | 4 |
| Kant et al39 | 2–4 mg of TAC 40 mg/mL | 0.05–0.1 mL of verapamil 2.5 mg/mL | 3 | Second injection after 1 week, third injection 3 weeks later |
| Saha and Mukhopadhyay43 | 40 mg/mL | – | Maximum 6 | 1 |
| Fitzpatrick45 | 1 mg | 5-FU 45 mg | 5–10 | – |
| Khan et al46 | 4 mg | 5-FU 45 mg | 8 | 1 |
| Tan et al71 | 40 mg/mL | – | – | 4 |
| Kassab and El Kharbotly63 | 40 mg/mL | 980 nm diode laser | 2–5 | – |
| Payapvipapong et al77 | 10 mg/mL | – | 3 | 4 |
Abbreviations: 5-FU, 5-fluorouracil; TAC, triamcinolone acetonide.